Skip to main content
Have a personal or library account? Click to login
Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?CME Cover

Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?CME

Open Access
|Oct 2019

References

  1. Siegel RL Miller KD Jemal A Cancer statistics, 2019 CA Cancer J Clin 2019 Jan 69 1 7 34
  2. Herrmann J Yang EH Iliescu CA Vascular Toxicities of Cancer Therapies: The Old and the New–An Evolving Avenue Circulation 2016 Mar 29 133 13 1272 89
  3. Faller N Limacher A Mean M Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study Am J Med 2017 Feb 130 2 198 206
  4. Streiff MB Holmstrom B Angelini D NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 J Natl Compr Canc Netw 2018 Nov 16 11 1289 303
  5. Carrier M Abou-Nassar K Mallick R Apixaban to Prevent Venous Thromboembolism in Patients with Cancer N Engl J Med 2019 Feb 21 380 8 711 9
  6. Melloni C Dunning A Granger CB Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial Am J Med 2017 Dec 130 12 1440 8.e1
  7. Raskob GE van Es N Verhamme P Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism N Engl J Med 2018 Feb 15 378 7 615 24
  8. Young AM Marshall A Thirlwall J Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) J Clin Oncol 2018 Jul 10 36 20 2017 2023
  9. Khorana AA Soff GA Kakkar AK Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer N Engl J Med 2019 Feb 21 380 8 720 8
  10. Khorana AA Kuderer NM Culakova E Lyman GH Francis CW Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 2008 May 15 111 10 4902 7
  11. Biondi-Zoccai G Malavasi V D'Ascenzo F Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses HSR Proc Intensive Care Cardiovasc Anesth 2013 5 1 40 54
  12. O'Neal WT Claxton JS Sandesara PB Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer J Am Coll Cardiol 2018 Oct 16 72 16 1913 22
  13. Helling TS Kaswan S Miller SL Tretter JF Practice patterns in the use of retrievable inferior vena cava filters in a trauma population: a single-center experience J Trauma 2009 Dec 67 6 1293 6
  14. Ray CE Jr Mitchell E Zipser S Kao EY Brown CF Moneta GL Outcomes with retrievable inferior vena cava filters: a multicenter study J Vasc Interv Radiol 2006 Oct 17 10 1595 604
  15. Sarosiek S Crowther M Sloan JM Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center JAMA Intern Med 2013 Apr 8 173 7 513 7
  16. McLoney ED Krishnasamy VP Castle JC Yang X Guy G Complications of Celect, Gunther tulip, and Greenfield inferior vena cava filters on CT follow-up: a single-institution experience J Vasc Interv Radiol 2013 Nov 24 11 1723 9
  17. Rowell NP Gleeson FV Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review Clin Oncol (R Coll Radiol) 2002 Oct 14 5 338 51
  18. Hart RG Diener HC Yang S Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial Stroke 2012 Jun 43 6 1511 7
  19. Hankey GJ Stevens SR Piccini JP Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation Stroke 2014 May 45 5 1304 12
  20. Carney BJ Uhlmann EJ Puligandla M Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors J Thromb Haemost 2019 Jan 17 1 72 6
  21. Armenian SH Sun CL Vase T Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease Blood 2012 Nov 29 120 23 4505 12
  22. Tichelli A Bucher C Rovo A Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation Blood 2007 Nov 1 110 9 3463 71
  23. Tichelli A Gratwohl A Vascular endothelium as ‘novel’ target of graft-versus-host disease Best Pract Res Clin Haematol 2008 Jun 21 2 139 48
  24. Griffith ML Savani BN Boord JB Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management Blood 2010 Aug 26 116 8 1197 204
  25. Rackley C Schultz KR Goldman FD Cardiac manifestations of graft-versus-host disease Biol Blood Marrow Transplant 2005 Oct 11 10 773 80
  26. Li W Croce K Steensma DP McDermott DF Ben-Yehuda O Moslehi J Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors J Am Coll Cardiol 2015 Sep 8 66 10 1160 78
  27. Eikelboom JW Connolly SJ Bosch J Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease N Engl J Med 2017 Oct 5 377 14 1319 30
  28. Anand SS Caron F Eikelboom JW Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial J Am Coll Cardiol 2018 May 22 71 20 2306 15
  29. Kim HS Preece SR Black JH Pham LD Streiff MB Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients J Vasc Surg 2008 Feb 47 2 388 94
  30. Mewissen MW Seabrook GR Meissner MH Cynamon J Labropoulos N Haughton SH Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry Radiology 1999 Apr 211 1 39 49
  31. Leopardi M Di Marco E Musilli A Ricevuto E Bruera G Ventura M Effects of Chemotherapy in Patients with Concomitant Aortic Aneurysm and Malignant Disease Ann Vasc Surg 2017 Nov 45 268 e13 268.e20
  32. Palm SJ Russwurm GP Chang D Rozenblit AM Ohki T Veith FJ Acute enlargement and subsequent rupture of an abdominal aortic aneurysm in a patient receiving chemotherapy for pancreatic carcinoma J Vasc Surg 2000 Jul 32 1 197 200
  33. Martin ZL Mastracci TM Greenberg RK Morales JP Bena J The effect of chemotherapy for malignancy on the natural history of aortic aneurysm J Vasc Surg 2015 Jan 61 1 50 7
Language: English
Page range: 289 - 299
Published on: Oct 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2019 Jose Alvarez-Cardona, Joshua Mitchell, Daniel Lenihan, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.